Hypercortisolism and hemostasis;Hiperkortyzolemia a układ hemostazy

Polski Merkuriusz Lekarski

Volumn 26, Issue 152, 2009, Pages 142-144

  Światkowska Stodulska, Renata ^a   Babińska, Anna ^a   Sworczak, Kryzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Coagulation and fibrinolysis; Hypercoagulable state; Hypercortisolism

Indexed keywords

ANTICOAGULANT AGENT; CYTOKINE;

ANIMAL; CUSHING SYNDROME; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLISM; PATHOPHYSIOLOGY; REVIEW; THROMBOEMBOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; ANTICOAGULANTS; CUSHING SYNDROME; CYTOKINES; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; HYPERHOMOCYSTEINEMIA; THROMBOEMBOLISM;

EID: 61449117141     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Abdu T.A., Elhadd T., Pfeifer M., Clayton R.N.: Endothelial dysfunction in endocrine disease. Trends Endocrinol. Metab., 2001, 12, 257-265.
2. Andrews R.C., Walker B.R.: Glucocorticoids and insulin resistance: old hormones, new targets. Clin. Sci. (Lond), 1999, 96, 513-523.
3. Ashizawa N., Takagi M., Seto S. i wsp.: Serum adiponectin and leptin in a patient with Cushing's syndrome before and after adrenalectomy. Intern. Med., 2007, 46, 383-385.
4. Bhatt H.R.: Antagonistic effects of pentagastrin and cortisol on plasma level, urinary excretion and hepatic and renal uptake of vitamin B12 after intravenous injection in the cat. J. Physiol., 1979, 296, 88P.
5. Boscaro M., Sonino N., Scarda A. i wsp.: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J. Clin. Endocrinol. Metab., 2002, 873, 3662-3666.
6. Brotman D.J., Girod J.P., Posch A. i wsp.: Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb. Res., 2006, 118, 247-252.
7. Casonato A., Pontara E., Boscaro M. i wsp.: Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul. Fibrinolysis, 1999, 10, 145-151.
8. Chan P., Huang T.Y., Shieh S.M. i wsp.: Thrombophilia in Patients with Hypertriglyceridemia. J. Thromb. Thrombolysis, 1997, 4, 425-429.
9. Dal Bo Zanon R., Fornasiero L., Boscaro M. i wsp.: Increased factor VIII associated activities in Cushing's syndrome: a propable hypercoagulable state. Thromb. Haemost., 1982, 47, 116-117.
10. Darmon P., Dadoun R, Boullu-Ciocca S. i wsp.: Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity. Am. J. Physiol. Endocrinol. Metab., 2006, 291, 995-1002.
11. Faggiano A., Melis D., Alfieri R. i wsp.: Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease. J. Clin. Endocrinol. Metab., 2005, 90, 6616-6622.
12. Fatti L.M., Bottasso B., Invitti C. i wsp.: Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J. Endocrinol. Invest., 2000, 23, 145-150.
13. Folsom A.R., Qamhieh H.T., Wing R.R. i wsp.: Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler. Thromb., 1993, 13, 162-169.
14. Gallagher N.D., Foley K.E.: Corticosteroids and the development of intrinsic factor-mediated vitamin B12 absorption in the rat. Gastroenterology, 1972, 62, 247-254.
15. Halleux C.M., Declerck P.J., Tran S.L. i wsp.: Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catcholamines. J. Clin. Endocrinol. Metab., 1999, 84, 4097-4105.
16. Ikkala E., Myllyla G., Pelkonen R. i wsp.: Haemostatic parameters in Cushing's syndrome. Acta Med. Scand., 1985, 217, 507-511.
17. Jacoby R.C., Owings J.T., Ortega T. i wsp.: Biochemical basis for the hypercoagulable state seen in Gushing syndrome. Arch. Surg., 2001, 136, 1003-1006.
18. Juhan-Vague I., Alessi M.C., Mavri A., Morange P.E.: Plasminogen activator-1, inflammation, obesity, insulin resistance and vascular risk. J. Thromb. Haemost., 2003, 1, 1575-1579.
19. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G.: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab., 2001, 280, 745-751.
20. Kohler H.P.: Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med. Wkly, 2002, 132, 241-252.
21. Krsek M., Silha J.V., Jezkova J. i wsp.: Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin. Endocrinol. (Oxf), 2004, 60, 350-357.
22. Łubińska M., Kazimierska E., Sworczak K.: Hiperhomocysteinemia jako nowy czynniki ryzyka wielu chorób. Adv. Clin. Exp. Med., 2006, 15, 897-903.
23. Lustig R.H., Sen S., Soberman J.E., Velasquez-Mieyer P.A: Obesity, leptin resistance, and the effects of insulin reduction. Int. J. Obes. Relat. Metab. Disord., 2004, 28, 1344-1348.
24. Masuzaki H., Ogawa Y., Hosoda K. i wsp.: Gluccocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J. Clin. Endocrinol. Metab., 1997, 82, 2542-2547.
25. Meigs J.B., Mittleman M.A., Nathan D.M. i wsp.: Hyperinsulinemia, Hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA, 2000, 283, 221-228.
26. Morange P.E., Aubert J., Peiretti F. i wsp.: Glucocorticoids and insulin promote plasminogen activator inhibitor-1 production by human adipose tissue. Diabetes, 1999, 48, 890-895.
27. Mutch N.J., Wilson H.M., Booth N.A.: Plasminogen activator inhibitor-1 and haemostasis in obesity. Proc. Nutr. Soc., 2001, 60, 341-347.
28. Patrassi G.M., Dal Bo Zanon R., Boscaro M. i wsp.: Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb. Haemost., 1985, 54, 518-520.
29. Patrassi G.M., Sartori M.T, Viero M.L. i wsp.: The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagul. Fibrinolysis, 1992, 3, 789-793.
30. Rosenfeld B.A., Faraday N., Campbell D. i wsp.: Hemostatic effects of stress hormone infusion. Anesthesiology, 1994, 81, 1116-1126.
31. Schafroth U., Godang K., Ueland T. i wsp.: Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index. J. Endocrinol. Incest., 2000, 23, 349-355.
32. Sieminska L., Marek B., Kajdaniuk D. i wsp.: Adiponektyna - ogniwo łaczace otyłość, miażdżyce i cukrzyce. Pol. Arch. Med. Wewn., 2002, 108, 1245-1251.
33. Skurk T., van Harmelen V., Lee Y.M. i wsp.: Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients. Horm. Metab. Res., 2002, 34, 659-663.
34. Small M., Lowe G.D., Forbes C.D., Thomson J.A.: Thromboembolic complications in Cushing's syndrome. Clin. Endocrinol.(Oxf) 1983, 19, 503-511.
35. Steinberg H.O., Chaker H., Learning R. i wsp.: Obesity/Insulin resistance in associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest., 1996, 97, 2601-2610.
36. Światkowska-Stodulska R., Babinska A., Sworczak K.: Wpływ wybranych hormonów na poszczególne parametry układu hemostazy. Wiad. Lek., 2007, 60, 390-393.
37. Terzolo M., Allasino B., Bosio S. i wsp.: Hyperhomocysteinemia in patients with Cushing's syndrome. J. Clin. Endocrinol. Metab., 2004, 89, 3745-3751.
38. Vamberque A., Rugeri L., Gaveriaux V. i wsp.: Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age. Thromb. Res., 2001, 101, 367-375.
39. Wallace A.M., McMahon A.D., Packard C.J. i wsp.: Plasma leptin and risk of cardiovascular disease in the west Scotland coronary prevent/on study (WOSCOPS). Circulation, 2001, 104, 3052-3056.
40. Westerbacka J., Yki-Jarvinen H., Turpeinen A. i wsp.: Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler. Thromb. Vasc. Biol., 2002, 22, 167-172.
41. Zawilska K.: Czynniki ryzyka zakrzepów tetniczych. W: Zakrzepy i zatory. Łopaciuk S. (red.). Wdawnictwo lekarskie PZWL, Warszawa 1996, 141-151.